Strata Critical Medical (SRTA) Receivables - Net (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Receivables - Net data on file, last reported at $39.6 million in Q1 2026.

• Quarterly Receivables - Net rose 78.97% year-over-year to $39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.6 million (up 78.97% YoY) and the FY2025 annual result came in at $40.0 million, up 101.58% from the prior year.
• Receivables - Net declined to $39.6 million in Q1 2026 per SRTA's latest filing, from $40.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $40.0 million in Q4 2025 and bottomed at $6.0 million in Q1 2022.
• The 5-year median for Receivables - Net is $22.1 million (2025), against an average of $22.5 million.
• The widest annual swing landed in 2022, when Receivables - Net jumped 464.95%; it then declined 6.04% in 2025.
• Tracing SRTA's Receivables - Net over 5 years: stood at $10.9 million in 2022, then soared by 93.11% to $21.0 million in 2023, then decreased by 5.63% to $19.8 million in 2024, then surged by 101.58% to $40.0 million in 2025, then retreated by 0.89% to $39.6 million in 2026.
• Per Business Quant, the three latest SRTA Receivables - Net figures stand at $39.6 million (Q1 2026), $40.0 million (Q4 2025), and $37.5 million (Q3 2025).

Peer Comparison